Form 4: Forte Biosciences Director Receives Stock Units

Forte Biosciences, Inc. director Shivpreet Singh Kapoor was granted 18,353 restricted stock units, vesting on the first annual stockholder meeting after May 29, 2026.

Summary

• Shivpreet Singh Kapoor, a Director at Forte Biosciences, Inc., was granted 18,353 Restricted Stock Units (RSUs) on May 29, 2026.
• These RSUs represent a contingent right to receive one share of Forte Biosciences' Common Stock.
• The vesting condition for 100% of these RSUs is tied to the first annual stockholder meeting occurring after May 29, 2026, provided Mr. Kapoor remains a Service Provider through that date.
• Following the transaction, Mr. Kapoor beneficially owns 18,353 shares of Common Stock directly.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it represents a standard equity grant to a director rather than a significant financial event or strategic shift.

Positives

• Director compensation in the form of equity aligns management interests with shareholders.
• Grant of RSUs indicates confidence in the company's future prospects, as vesting is tied to future events.
• The grant is a standard form of equity compensation for directors.

Negatives

• The vesting is contingent on continued service, meaning the shares are not immediately owned.
• The specific value of the grant is not disclosed, only the number of units.

Risks

• The primary risk is that the director may not remain a Service Provider until the vesting date, forfeiting the RSUs.
• The value of the RSUs is subject to the future stock price performance of Forte Biosciences.

Future Outlook

The future outlook for the RSUs is dependent on the company's performance and the director's continued service, with vesting scheduled for the first annual stockholder meeting after May 29, 2026.

Industry Context

StockSavvy.ai notes that equity grants to directors are a common practice in the biotechnology and pharmaceutical sectors, aiming to incentivize long-term commitment and align executive interests with shareholder value.

Corporate Governance

Related Party Transactions

• The grant of Restricted Stock Units to Director Shivpreet Singh Kapoor is a related party transaction.

Stakeholder Impact

• Shareholders: The grant dilutes ownership slightly but aligns director incentives with long-term company performance.
• Employees: This filing does not directly impact employees, but it is part of the overall compensation structure.
• Management: Reinforces the alignment of director compensation with company stock performance.

Next Steps

• The RSUs will vest on the first annual stockholder meeting after May 29, 2026, contingent on Shivpreet Singh Kapoor's continued service.
• The company will continue to operate under its 2021 Equity Incentive Plan.

Key Dates

Keywords

Forte Biosciences, FBRX, Form 4, Restricted Stock Units, RSU, Director Compensation, Equity Incentive Plan, Beneficial Ownership, Vesting Schedule